Mitogen stimulated lymphocyte transformation

Details Mitogen stimulated lymphocyte transformation Mitogen stimulated lymphocyte transformation

1979-08-30

1981-11-24

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

23230B, 424 2, 435 6, G01N 3360, G01T 100

Patent

active

043024378

ABSTRACT:
Mitogen stimulated transformation of blood lymphocytes is effected with a whole blood sample of a quantity of no greater than 0.5 ml, and a mitogen to whole blood sample ratio which prevents agglutination of blood cells to thereby facilitate uniform uptake of reagents by the lymphocytes in subsequent testing. Lymphocyte transformation can be measured by use of a radioisotope, and the technique is particularly suitable for measuring vitamin deficiency by a dU or thymidine suppression test, or for determining lymphocytic malignancy. The use of a whole blood culture eliminates lymphocyte separation, and the use of micro quantities of blood extends clinical application to routine laboratories and pediatric patients.

REFERENCES:
Das et al., Clin. Chem., vol. 26, No. 1, 1980, pp. 72-77.
Das et al., Clin. Res., vol. 26, 1978, p. 618A.
Park et al., Proc. Natl. Acad. Sci. USA, 99, 371-373, (1972).
Pellegrino, Clin. Immunol. Immuno Pathol., 2, 67-73, (1973).
Junge et al., Clin. Exp. Immunol., 7, 431-437, (1970).

Affiliated with

Also associated with

Rating

Mitogen stimulated lymphocyte transformation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitogen stimulated lymphocyte transformation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitogen stimulated lymphocyte transformation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2174667